In this review, only IDH wild-type grade IV glioblastoma and not “IDH- mutant type IV astrocytoma” will be discussed since the two grade IV malignancies differ in genetic makeup, progression rate, and disease prognosis. This evidence concerns the gene IDH1 and glioblastoma.